This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners in the field of neurology and sleep medicine. Program Overview
The overall aim of this program is to improve accuracy of diagnosis of patients with excessive sleepiness (ES), highlighting the specific etiologies that can manifest as ES in neurology practice and selecting management strategies targeted appropriately to achieve the best possible outcomes for patient care. Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Global Education Group (Global) and HealthmattersCME. Global is accredited by the ACCME to provide continuing medical education for physicians. Physician Credit Designation
Global Education Group designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credits™
. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Fee Information & Refund/Cancellation Policy
There is no fee for this educational activity.
For information about the accreditation of this program, please contact Global at 303-395-1782
or firstname.lastname@example.org. Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The planners and managers
reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity: Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and HealthmattersCME do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instructions to Receive Credit
In order to receive credit for this activity, the participant must complete the online post-test, with a passing score of 70% or higher, and the online evaluation form.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
|Name of Faculty or Presenter ||Reported Financial Relationship |
|Paul P. Doghramji, MD ||Consultant/Independent Contractor: |
AstraZeneca, Merck, Teva Pharmaceutical
Takeda, Teva Pharmaceutical Industries
|Emmanuel Mignot, MD, PhD ||Dr Mignot has no real or apparent |
conflicts of interest to report, nor any
financial relationships to disclose.
|Phyllis C. Zee, MD, PhD ||Consultant/Independent Contractor: |
Aptalis; Jazz Pharmaceuticals; Merck;
Vanda Pharmaceuticals, Inc.
|Name of Planner or Manager ||Reported Financial Relationship |
|Andrea Funk ||Nothing to disclose |
|Amanda Glazar, PhD ||Nothing to disclose |
|Ashley Marostica, RN, MSN ||Nothing to disclose |
|James Murphy ||Nothing to disclose |
This activity is jointly sponsored by Global Education Group and HealthmattersCME.
This activity is supported by an independent educational grant from Jazz Pharmaceuticals. COURSE VIEWING REQUIREMENTS
|Supported Browsers: |
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 5.0+ for Mac OSX 10.5 and above
For video playback, install the latest version of Flash or Quicktime.
|Supported Phones & Tablets: |
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above